Search

Start Over Keyword Mutations

  • Surveillance of SARS-CoV-2 variants of concern by identification of single nucleotide polymorphisms in the spike protein by a multiplex real-time PCR

    Surveillance of SARS-CoV-2 variants of concern by identification of single nucleotide polymorphisms in the spike protein by a multiplex real-time PCR
    Authors:Laksiri Gomes, University of Sri JayewardenepuraChandima Jeewandara, University of Sri JayewardenepuraTibutius P Jayadas, University of Sri JayewardenepuraOsanda Dissanayake, University of Sri JayewardenepuraMichael Harvie, University of Sri JayewardenepuraDinuka Guruge, Colombo Municipal CouncilVigeetha Withanage, Ministry of Health Sri LankaPasyodun Koralage Buddhika Mahesh, Ministry of Health Sri LankaWajira Rajapakse, Ministry of Health Sri LankaRajanthi Ramachandran, Ministry of Health Sri LankaVenoden Dharmarajan, Ministry of Health Sri LankaIndika Pathiraja, Ministry of Health Sri LankaAnusha Sanjeewani, Ministry of Health Sri LankaPriyantha Bandara, Ministry of Health Sri LankaGeetha Nanayakkara, Ministry of Health Sri LankaVaithehi R Francis, Eastern University, Sri LankaAnanda Kithsiri, Ministry of Health Sri LankaDilini Anushika Edirisinghe, Ministry of Health Sri LankaKaushalya De Silva, Ministry of Health Sri LankaRuwan Wijayamuni, Colombo Municipal CouncilGraham S Ogg, University of OxfordJesse Waggoner, Emory UniversityGathsaurie Neelika Malavige, University Sri Jayewardenepura
    Date:2021
    Publisher:ELSEVIER
    Publication Version:Final Published Version

  • Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma

    Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma
    Authors:Andrew B. Lassman, Columbia UniversityKenneth D. Aldape, Toronto General HospitalPeter J. Ansell, Abbvie IncEarle Bain, Abbvie IncWalter Curran Jr, Emory UniversityMarica Eoli, Fondazione IRCCS Istituto Neurologico Carlo BestaPim J. French, Erasmus MC Cancer InstituteManabu Kinoshita, Osaka International Cancer InstituteJim Looman, Abbvie IncMinesh Mehta, Baptist Hospital MiamiYoshihiro Muragaki, Tokyo Womens Medical University HospitalYoshitaka Narita, National Cancer Center HospitalChristopher Ocampo, Abbvie IncLisa Roberts-Rapp, Abbvie IncMinghao Song, Abbott MolecularMichael A. Vogelbaum, Cleveland ClinicAnnemiek M. E. Walenkamp, University of GroningenTony J. C. Wang, Columbia UniversityPeixin Zhang, American College of RadiologyMartin J. van den Bent, Erasmus MC Cancer Institute
    Date:2019
    Publisher:Springer
    Publication Version:Author Accepted Manuscript (After Peer Review)
    License:Creative Commons Attribution-NonCommercial 4.0 International

  • In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer

    In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer
    Authors:Z. Ping Lin, Yale UniversityNour N. Al Zouabi, Yale UniversityMark L. Xu, Yale UniversityNicole E. Bowen, Emory UniversityTerence L. Wu, Yale UniversityEthan S. Lavi, Yale UniversityPamela H. Huang, Yale UniversityYong-Lian Zhu, Yale UniversityBaek Kim, Emory UniversityElena S. Ratner, Yale University
    Date:2021
    Publisher:Nature Portfolio
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

    mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates
    Authors:Kizzmekia S. Corbett, NIAIDAnne P. Werner, NIAIDSarah O' Connell, NIAIDMatthew Gagne, NIAIDLilin Lai, Emory UniversityJuan I. Moliva, NIAIDBarbara Flynn, NIAIDAngela Choi, ModernaMatthew Koch, ModernaKathryn E. Foulds, NIAIDShayne F. Andrew, NIAIDDillion R. Flebbe, NIAIDEvan Lamb, NIAIDSaule T. Nurmukhambetova, NIAIDSamantha J. Provost, NIAIDKevin W. Bock, NIAIDMahnaz Minai, NIAIDBianca M. Nagata, NIAIDAlex Van Ry, BioqualZackery Flinchbaugh, BioqualTimothy S. Johnston, NIAIDElham Bayat Mokhtari, NIAIDPrakriti Mudvari, NIAIDAmy R. Henry, NIAIDFarida Laboune, NIAIDBecky Chang, BioqualMaciel Porto, BioqualJaclyn Wear, BioqualGabriela S. Alvarado, NIAIDSeyhan Boyoglu-Barnum, NIAIDJohn-Paul M. Todd, NIAIDBridget Bart, BioqualAnthony Cook, BioqualAlan Dodson, BioqualLaurent Pessaint, BioqualKatelyn Steingrebe, BioqualSayda Elbashir, ModernaManjari Sriparna, NIAIDAndrew Pekosz, Johns Hopkins UniversityHanne Andersen, BioqualKai Wu, ModernaDarin K. Edwards, ModernaSwagata Kar, BioqualMark G. Lewis, BioqualEli Boritz, NIAIDIan Moore, Emory UniversityAndrea Carfi, ModernaMehul Suthar, Emory UniversityAdrian McDermott, NIAIDMario Roederer, NIAIDMartha C. Nason, NIAIDNancy J. Sullivan, NIAIDDaniel C. Douek, NIAIDBarney S. Graham, NIAIDRobert A. Seder, NIAID
    Date:2021
    Publisher:Nature Portfolio
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer

    Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer
    Authors:David E. Gerber, University of Texas Southwestern Medical CenterD. Ross Camidge, University of ColoradoDaniel Morgensztern, Washington UniversityJeremey Cetnar, Oregon Health and Science UniversityRonan J. Kelly, Johns Hopkins UniversitySuresh Ramalingam, Emory UniversityDavid R. Spigel, Sarah Cannon Research InstituteWoondong Jeong, University of Texas Health Science CenterPier P. Scaglioni, University of Texas Southwestern Medical CenterSong Zhang, University of Texas Southwestern Medical CenterMarilyn Li, Baylor College of MedicineDavid T. Weaver, Verastem IncLouis Vaikus, Verastem IncMitchell Keegan, Verastem IncJoanna Horobin, Verastem IncTimothy F. Burns, University of Pittsburgh
    Date:2020
    Publisher:Elsevier Ireland Ltd.
    Publication Version:Author Accepted Manuscript (After Peer Review)
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

  • COVID-19: comprehensive review on mutations and current vaccines

    COVID-19: comprehensive review on mutations and current vaccines
    Authors:Ananda Vardhan Hebbani, Indian Academy Degree CollegeSwetha Pulakuntla, REVA UniversityPadmavathi Pannuru, DR Biosciences, Research and Development InstituteSreelatha Aramgam, Emory UniversityKameswara Rao Badri, Morehouse School of MedicineVaddi Damodara Reddy, REVA University
    Date:2021
    Publisher:Springer (part of Springer Nature)
    Publication Version:Final Published Version

  • The ciliary phosphatidylinositol phosphatase Inpp5e plays positive and negative regulatory roles in Shh signaling

    The ciliary phosphatidylinositol phosphatase Inpp5e plays positive and negative regulatory roles in Shh signaling
    Authors:Sandii Constable, Emory UniversityAlyssa B. Long, Emory UniversityKatharine A. Floyd, Emory UniversityStéphane Schurmans, University of LiegeTamara Caspary, Emory University
    Date:2020
    Publisher:Company Biologists Ltd.
    Publication Version:Final Published Version

  • Unaccompanied mechanosensory domain mediates low expression of glycoprotein Ib alpha: implications for Bernard-Soulier syndrome

    Unaccompanied mechanosensory domain mediates low expression of glycoprotein Ib alpha: implications for Bernard-Soulier syndrome
    Authors:Yue Tao, Shanghai Jiao Tong UniversityChi Gan, Shanghai Jiao Tong UniversityXiaoqin Zhang, Shanghai Jiao Tong UniversityLanbo Liu, Shanghai Jiao Tong UniversityPhilip M. Zakas, Emory UniversityChristopher Doering, Emory UniversityXi Mo, Shanghai Jiao Tong UniversityRenhao Li, Emory University
    Date:2019
    Publisher:Wiley
    Publication Version:Author Accepted Manuscript (After Peer Review)

  • TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

    TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML
    Authors:Jayakumar Vadakekolathu, Nottingham Trent UniversityCatherine Lai, MedStar Georgetown University HospitalStephen Reeder, Nottingham Trent UniversitySarah E. Church, NanoString Technologies IncTressa Hood, NanoString Technologies IncAnbarasu Lourdusamy, University of NottinghamMichael P. Rettig, Washington UniversityIbrahim Aldoss, City Hope National Medical CenterAnjali s. Advani, Cleveland ClinicJohn Godwin, Providence Cancer CenterMatthew J. Wieduwilt, University of California San DiegoMartha Arellano, Emory UniversityJohn Muth, MacroGenics IncTung On Yau, Nottingham Trent UniversityFarhad Ravandi, University of Texas MD Anderson Cancer CenterKendra Sweet, H. Lee Moffitt Cancer Center and Research InstituteHeidi Altmann, Technische Universitat DresdenGemma A. Foulds, Nottingham Trent UniversityFriedrich Stoelzel, Technische Universitat DresdenJan Moritz Middeke, Technische Universitat DresdenMarilena Ciciarello, University Hospital S Orsola MalpighiAntonio Curti, University Hospital S Orsola MalpighiPeter J. M. Valk, Erasmus MCBob Loewenberg, Erasmus MCIvana Gojo, Johns Hopkins UniversityMartin Bornhaeuser, Technische Universitat DresdenJohn F. DiPersio, Washington UniversityJan K. Davidson-Moncada, MacroGenics IncSergio Rutella, Nottingham Trent University
    Date:2020
    Publisher:American Society for Hematology
    Publication Version:Final Published Version

  • Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention

    Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
    Authors:Anne Marie Lennon, Johns Hopkins UniversityAdam H. Buchanan, GeisingerIsaac Kinde, Thrive Earlier Detection Corp.Andrew Warren, Thrive Earlier Detection Corp.Ashley Honushefsky, GeisingerAriella T. Cohain, Thrive Earlier Detection Corp.David H. Ledbetter, GeisingerAlfred Sanfilippo, Emory UniversityKathleen Sheridan, GeisingerDillenia Rosica, GeisingerChristian S. Adonizio, GeisingerHee Jung Hwang, Thrive Earlier Detection CorpKamel Lahouel, Johns Hopkins UniversityJoshua D. Cohen, Johns Hopkins UniversityChristopher Douville, Johns Hopkins UniversityAalpen A. Patel, GeisingerLeonardo N. Hagmann, Thrive Earlier Detection Corp.David D. Rolston, GeisingerNirav Malani, Thrive Earlier Detection Corp.Shibin Zhou, Johns Hopkins UniversityChetan Bettegowda, Johns Hopkins UniversityDavid L. Diehl, GeisingerBobbi Urban, Thrive Earlier Detect CorpChristopher D. Still, GeisingerLisa Kann, Thrive Earlier Detection Corp.Julie I. Woods, GeisingerZachary M. Salvati, GeisingerJoseph Vadakara, GeisingerRosemary Leeming, GeisingerPrianka Bhattacharya, GeisingerCarroll Walter, GeisingerAlex Parker, Thrive Earlier Detection Corp.Christoph Lengauer, Thrive Earlier Detection Corp.Alison Klein, Johns Hopkins UniversityCristian Tomasetti, Johns Hopkins UniversityElliot K. Fishman, Johns Hopkins UniversityRalph H. Hruban, Johns Hopkins UniversityKenneth W. Kinzler, Johns Hopkins UniversityBert Vogelstein, Johns Hopkins UniversityNickolas Papadopoulos, Johns Hopkins University
    Date:2020
    Publisher:American Association for the Advancement of Science
    Publication Version:Author Accepted Manuscript (After Peer Review)